SUBSCRIBE
SUBSCRIBE
News   Business

Virbac Corporation Exercises Its Options for a Commercial Licence Agreement to Use Vivalis’ EBx(R) Platform

April 1, 2008 | 
1 min read

NANTES, FRANCE--(Marketwire - April 01, 2008) - Highlighted Links VIRBAC EXERCISES ITS OPTION FOR A COMMERCIAL LICENCE AGREEMENT TO USE VIVALIS’ EBx® PLATFORM FOR THE PRODUCTION OF SEVERAL VACCINES.

Alliances Europe
MORE ON THIS TOPIC
Image of Houston downtown park and skyline in the morning
Business
Houston’s Life Sciences Scene Continues Boosting Its Reputation
March 13, 2025
 · 
6 min read
 · 
Angela Gabriel
piggy bank behind umbrella to cover and protect from downturn arrow. Protection or defensive stock in economy crisis
Mergers & acquisitions
Acelyrin Adopts Poison Pill to Ward Off Tang Capital Buy
March 13, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Business
“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
March 13, 2025
 · 
1 min read
 · 
Lori Ellis
A human hand showing dollar golden coins in the jar with a colored background. Collage Art of finance
Manufacturing
J&J, Legend Pump $150M Into Manufacturing in Bid to Double Carvykti Production
March 13, 2025
 · 
2 min read
 · 
Tristan Manalac